Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/23215
Title: Anti-troponin antibodies following myocardial infarction
Contributor(s): O'Donohoe, Tom J (author); Ketheesan, Natkunam (author); Schrale, Ryan G (author)
Publication Date: 2017
Open Access: Yes
DOI: 10.1016/j.jjcc.2016.07.018
Handle Link: https://hdl.handle.net/1959.11/23215
Open Access Link: http://dx.doi.org/10.1016/j.jjcc.2016.07.018
Abstract: Recent improvements in medical and surgical coronary revascularization techniques have significantly improved outcomes for patients with acute myocardial infarction (MI). However, large infarctions are often followed by a poorly understood process of pathological ventricular remodelling, which fails to return the heart to its premorbid state. Although it remains incompletely understood, there is increasing interest in the role of the immune system in this process. One hypothesis is that released cardiac proteins become the focus of an immune response that results in the formation of functionally significant autoantibodies. This review summarizes the current literature, both human and animal, relating to the formation and clinical relevance of anti-troponin antibodies (ATAs) in patients with MI.
Publication Type: Journal Article
Source of Publication: Journal of Cardiology, 69(1), p. 38-45
Publisher: Elsevier BV
Place of Publication: The Netherlands
ISSN: 1876-4738
0914-5087
Field of Research (FOR): 119999 Medical and Health Sciences not elsewhere classified
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Statistics to Oct 2018: Visitors: 3
Views: 3
Downloads: 0
Appears in Collections:Journal Article
School of Science and Technology

Files in This Item:
3 files
File Description SizeFormat 
Show full item record

SCOPUSTM   
Citations

1
checked on Nov 30, 2018

Page view(s)

112
checked on Mar 5, 2019
Google Media

Google ScholarTM

Check

Altmetric

SCOPUSTM   
Citations

 

WEB OF SCIENCETM
Citations

 

Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.